Skip to content

Estimation of the Localization Accuracy of the Genicular Ablation Procedure Applied for Chronic Pain Suppression

Estimation of the Localization Accuracy of the Genicular Ablation Procedure Applied for Chronic Pain Suppression

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02873611
Enrollment
30
Registered
2016-08-19
Start date
2016-08-31
Completion date
2017-08-31
Last updated
2016-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

Estimation of the localization accuracy of the genicular ablation procedure applied for chronic pain suppression

Interventions

DEVICEMRI

patients will undergo an additional MRI testing of apprx. 0.5-1 hour.

PROCEDUREgenicular ablation procedure

Sponsors

TPM Medical Systems Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years and older. * Diagnosed with primary degenerative osteoarthritis. * Complaining of knee pains * Patients clinically eligible for genicular nerve ablation procedure non-electively based on physical examination * Patient signed ICF

Exclusion criteria

* Co-morbidities: patient suffers from neuropathy, bony tumors, traumatic fractures and DM. * Claustrophobic or failing cooperativity assessment of laying still during long MRI scans * Pregnancy or pregnancy suspicion * Enrolled in concurrent studies that may confound the results of this study * Clinical condition that in the investigator's opinion would not allow the subject to complete the study, e.g., tremor, extreme obesity, mental disorders.

Design outcomes

Primary

MeasureTime frame
Location and orientation of the relevant genicular nerves based on eye-balling inspection of MRI images by a radiologist6 months

Contacts

Primary ContactYehuda Fridman, MD
yehudaf@assuta.co.il972-3-7645262

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026